Proton-pump inhibitors are associated with increased cardiovascular risk regardless of concurrent clopidogrel use.
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use.
Absolute Event Rate: 0% vs 0%
Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel.
Charlot et al. (Tue,) reported a other. Proton-pump inhibitors are associated with increased cardiovascular risk regardless of concurrent clopidogrel use.